Overview

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Their proprietary platform seeks to deliver improved outcomes through the precise delivery of radiation to tumors.

Core services & business areas

Pharmaceutical Manufacturing

Therapeutic areas

RadiotherapeuticsOncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Plus Therapeutics, Inc. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Plus Therapeutics, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.